Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome

British Journal of Rheumatology

Volumn 35, Issue 12, 1996, Pages 1239-1243

  Amengual, O ^a   Atsumi, T ^a   Khamashta, M A ^a   Koike, T ^b   Hughes, G R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Anticardiolipin antibody; Antiphosphatidylserine antibodies; Systemic lupus erythematosus; Thrombosis

Indexed keywords

ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEINS; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED;

EID: 0030469470     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Roubey RAS. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other 'antiphospholipid' antibodies. Blood 1994;84:2854-67.
2. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
3. Khamashta MA, Hughes GRV. Antiphospholipid antibodies and .antiphospholipid syndrome. Curr Opin Rheumatol 1995;7:389-94.
4. Harris EN, Gharavi AE, Boey ML et al. Anti-cardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983;ii:1211-4.
5. Harris EN, Gharavi AE, Patel BM, Hughes GRV. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987;68:215-22.
6. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
7. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that induces a lipid-binding inhibitor of coagulation: β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
8. Galli M, Comfurius P, Maassen C et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:952-3.
9. Matsuura E, Igarashi Y, Yasuda T, Triplett DA, Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994;179:457-62.
10. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
11. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Matsuura E, Igarashi Y, Fujimoto M et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 1992;148:3885-91.
13. Hunt JE, Krilis S. The fifth domain of β-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J Immunol 1994;152:653-9.
14. Ichikawa K, Khamashta M, Koike T, Matsuura E, Hughes GRV. Reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome to β-glycoprotein I. Arthritis Rheum 1994;37:1453-61.
15. Cervera R, Khamashta MA, Font J et al. Systemic lupus erythematosus: Clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine 1993;72:113-24.
16. Alarcon-Segovia D, Deleze M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine 1989;68:353-65.
17. Love PE, Santoro SA. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 1990;112:682-9.
18. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predictive value of the anticardiolipin antibody test. Arch Intern Med 1986;146:2153-6.
19. Escalante A, Brey RL, Mitchell BD Jr, Dreiner U. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus. Am J Med 1995;98:559-65.
20. Martinuzzo ME, Forastiero RR, Carreras LO. Anti β2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995;89:397-402.
21. McNally T, Mackie IJ, Machin SJ, Isenberg DA. Increased level of β2 glycoprotein I antigen and β2 glycoprotein I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol 1995;34:1031-6.
22. Cabiedes J, Cabral AR, Alarcon-Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-β2-glycoprotein-I than with antiphospholipid antibodies. J Rheumatol 1995;22:1899-906.
23. Nimpf J, Wurm H, Kostner M. Interaction of β2-glycoprotein I with human blood platelets: Influences upon the ADP induced aggregation. Thromb Haemostasis 1985;54:397-401.
24. Schousboe I, Rasmussen MS. Synchronized inhibition of the phospholipid mediated autoactivation of Factor XII in plasma by β2-glycoprotein I and anti-β2-glycoprotein I. Thromb Haemostasis 1995;73:798-804.
25. Schousboe I. β2-glycoprotein I: Plasma inhibitor of contact activation of the intrinsic blood coagulation pathway. Blood 1985;66:1086-91.
26. Shi W, Chong B, Hogg P, Chesterman C. Anticardiolipin antibodies block the inhibition by β2-glycoprotein I of the factor Xa generating activity of platelets. Thromb Haemostasis 1993;70:342-5.